What Polypharmacy and CYP Covers in Practice
Polypharmacy and CYP is a focused educational review for teams who need to make sense of multiple medicines, supplements and enzyme pathways without losing the detail. It looks at the CYP450 family in a straightforward way, with attention to common interaction patterns, why some combinations matter more than others, and where the evidence is strong versus uncertain.
We prepare this material for clinicians, pharmacists and wellness practitioners working across Cape Town, Johannesburg, Pretoria, Durban and Bloemfontein. The aim is not to diagnose, treat or adjust medicine use, but to support better questions, cleaner medicine histories and more careful discussions with the person and their own doctor or pharmacist.
- Clear summaries of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 related considerations
- Plain-language notes on enzyme inhibition, induction and substrate competition
- Practical prompts for reviewing repeat prescriptions, OTC products and supplements
Sizes and Format Options for Different Teams
We keep the format flexible so the same topic can be used for a short consultation handout or a fuller internal teaching file. The core content stays evidence-based and readable, then the depth can be adjusted for the audience and time available.
- Short brief: 2 to 4 pages for quick team use or meeting notes
- Standard review: 6 to 10 pages for clinical education and journal club support
- Expanded pack: 12 to 20 pages with references, interaction notes and discussion prompts
Optionally we can prepare plain language summaries, slide notes or a reference list build alongside the main review. If the material is going into an in-house training session, we can also shape it into a talk outline or a workshop handout.
Where This Review Suits Best
This product suits situations where several medicines may affect the same CYP pathway, or where a person is using prescribed medicines together with products bought over the counter. It is useful for teams who need a cautious, well structured summary before discussing the case further with the person’s own doctor or pharmacist.
It can be especially helpful when the conversation includes older adults, long term medicine use, chronic disease care, or repeated changes to a treatment list. In South African practice, that often means balancing public and private sector records, incomplete histories and the practical reality of patients seeing more than one provider.
- Medicine reconciliation and interaction screening support
- Teaching material for pharmacist and clinician CPD style sessions
- Wellness practitioner education where medicine history needs careful context
- Case note development for internal discussion, not for diagnosis
How We Work With the Science
Our team reads the available literature carefully and keeps to established CYP450 knowledge only. That means no unsupported findings, no exaggerated claims and no advice that crosses into personal treatment decisions. The focus is on what the pathway usually does, how interactions are generally understood, and where the literature still needs caution.
Dr Luyanda Mbeki leads the organisation, with Ayesha Daniels on science writing, Pieter van Rooyen on clinical literature analysis, Naledi Molefe on education programme coordination, Sibusiso Khumalo on research project management and Taryn Naidoo on medical content editing. That mix helps keep the wording accurate and practical for South African readers who want the science explained plainly.
- Literature reviews and journal scans
- Interaction overviews with referenced notes
- Plain-language summaries for mixed audiences
- Training talks and curriculum support
What to Check When Ordering
Before requesting this review, it helps to send a clean list of the medicines, supplements and any known timing changes that matter to the question. If the issue is about a particular enzyme, name it clearly where possible. If not, we can help frame the review around the likely pathway overlap and the interaction questions that need attention.
- List of current prescription and non prescription products
- Known or suspected CYP pathway of interest
- Audience type, for example clinicians, pharmacists or wellness practitioners
- Preferred length and whether a slide deck or summary sheet is needed
- Any local setting details, such as public sector clinic use or private practice support
Clients usually reach us through the enquiry form on our contact page. From there we can confirm scope, wording style and whether the brief should be suited to Cape Town meetings, national remote teams or a blended format.
Care, Updating and Ongoing Use
This kind of educational material needs regular checking because medicine guidance, interaction cautions and terminology can change. We recommend reviewing the brief when a new medicine is added to a protocol, when a teaching group changes, or when the team needs a fresh reference list for a current discussion.
For practices dealing with high patient turnover, load shedding interruptions, or split records across more than one site, a clean summary can prevent confusion and reduce the need to repeat the same explanation in each meeting. It is also useful for teams that work in humid coastal settings where paper handouts, filing and routine document handling need a bit more care.
- Best used alongside current prescribing information and professional judgement
- Review again if the medicine list changes materially
- Store with the latest reference set so older notes do not stay in circulation
As always, people should speak to their own doctor or pharmacist about their medicines, especially if there are side effects, unclear interactions or more than one prescriber involved.
Key facts
| Product type | Educational literature review and brief |
|---|---|
| Core focus | CYP450 enzyme interpretation in polypharmacy |
| Typical formats | Short brief, standard review, expanded pack |
| Audience | Clinicians, pharmacists and wellness practitioners |
| Base | Rondebosch, Cape Town |
| Availability | South African teams, including Cape Town, Johannesburg, Pretoria, Durban and Bloemfontein |
